US equities
|
SPCX
$171.09
▲+0.00%
NVDA
$238.90
▲+0.00%
MU
$1,063.96
▲+0.00%
AMD
$631.75
▲+0.00%
TSLA
$378.73
▲+0.00%
SNDK
$1,704.16
▲+0.00%
SKHY
$195.02
▲+0.00%
SDEV
$3.94
▲+0.00%
SPCX
$171.09
▲+0.00%
NVDA
$238.90
▲+0.00%
MU
$1,063.96
▲+0.00%
AMD
$631.75
▲+0.00%
TSLA
$378.73
▲+0.00%
SNDK
$1,704.16
▲+0.00%
SKHY
$195.02
▲+0.00%
SDEV
$3.94
▲+0.00%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Articles published by Zag Bio
Zag Bio Advances ZAG-101 into Clinical Development for Type 1 Diabetes
October 05, 2026
From
Zag Bio
Via
Business Wire